AzTrials
AzTrials

Low Back Pain, MechanicalNCT05023005

Strain-Counterstrain Treatment of Piriformis Pain

A study testing Strain-Counterstrain treatment of piriformis muscle in people with Low Back Pain, Mechanical and Piriformis Syndrome, run by Loma Linda University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this investigator-initiated study is to provide an efficient and non-invasive treatment option for pain caused by the piriformis muscle. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Strain-Counterstrain treatment of piriformis muscle
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteUnited States
Study dates
Sep 2026to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 to 65 years of age
  • Tender point (or trigger point) in piriformis muscle determined by physical exam

Who cannot join

  • Less than 45 degrees of active hip flexion, less than 5 degrees of active hip internal rotation or less than 30 degrees of active hip external rotation, on side of affected piriformis
  • Unable to lay prone
  • Non-English speaker
  • Inability to attend 2 sessions within the same month
  • Active cancer
  • Pregnant
Show all 10Show fewer
  • Diagnosis of lumbar radiculopathy
  • Greater than grade 1 lumbar spondylolisthesis
  • Presence of lumbar region Pars Defect
  • Receiving massage, acupuncture, chiropractic treatments, osteopathic treatments during study period.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Roya Vahdatinia, DO contact

9095586202

rvahdatinia@llu.edu

Mickey Lui, DO contact

9095586202

Mickey.Lui@va.gov

United States1 site, 1 recruiting
  • Loma Linda University Health

    Loma Linda, California, 92350

    Mickey Lui, MD, 909-558-1000

    Recruiting

Other trials in United States

About this study

The purpose of this investigator-initiated study is to provide an efficient and non-invasive treatment option for pain caused by the piriformis muscle.

Read the detailed description

There are two arms to the study: treatment and sham. The treatment group will receive strain-counterstrain for the piriformis muscle. The sham group will receive strain-counterstrain treatment for the hamstring muscle.

There will be two treatments, 1-2 weeks apart ideally.

Participants will fill out the Oswestry Disability Index Questionnaire before the first treatment and after the second treatment (which is 1-2 weeks after the first treatment).

Participants will also identify pain using the Visual Analog Scale (VAS) before and after each treatment. Participants will identify pain at rest prior to treatment using VAS. Participant will then identify pain at the start of treatment while pressure is applied to the piriformis muscle (4.5kg/cm2) and post treatment while pressure is applied to the piriformis muscle (4.5 kg/cm2).

An algometer will be used pre and post each treatment (2 treatments that are 1-2 weeks apart) to objectively measure any change in pain pressure threshold.

Being tested
Strain-Counterstrain treatment of piriformis muscle
Medical subject headings
Low Back Pain, Piriformis Muscle Syndrome, Signs and Symptoms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Strain-Counterstrain treatment of piriformis muscleOther

    Participant will lay prone on table with affected leg close to edge of table. Piriformis muscle tender point is identified and palpated. Then patient leg is passively moved off table and passive hip flexion, abduction, and possible internal/external rotation is added to reduce tender point by 70% or more. This is done passively. This position is held for 90 seconds and then participant is passively returned back to neutral prone position with leg on table. Tender point is palpated again to reassess for change in pain (using subjective visual analog scale). An algometer is also used pre and post to assess objective change in pressure pain threshold.

Study groups in NCT05023005
Study groupRoleWhat they receive
Piriformis Strain-CounterstrainExperimentalThe treatment group will receive strain-counterstrain for the piriformis muscle.
Receives: Other: Strain-Counterstrain treatment of piriformis muscle
Hamstring Strain-CounterstrainSham comparatorThe sham group will receive strain-counterstrain treatment for the hamstring muscle.
Receives: Other: Strain-Counterstrain treatment of piriformis muscle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Algometer - Change in pressure pain threshold

    Objective improvement in pressure/pain threshold

    Measured: Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.

Secondary outcomes (2)
  1. Change in Visual Analog Scale

    Subjective improvement in low back/leg pain

    Measured: Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.

  2. Change in Oswestry Disability Index

    Assesses pain with doing different activities (sleeping, walking, sitting, etc), assesses ability to do activities of daily living

    Measured: Before first treatment and after second treatment. Each treatment is 1-2 weeks apart (anticipated).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2021
  2. Study startSep 2026 (estimated)
  3. Primary completionSep 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
There are two arms to the study: treatment and sham. The treatment group will receive strain-counterstrain for the piriformis muscle. The sham group will receive strain-counterstrain treatment for the hamstring muscle.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05023005
Sponsor's protocol ID
5210286
Status last verified
Apr 2026
First submitted
11 Aug 2021
Last updated
24 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Strain-Counterstrain treatment of piriformis muscle in people with Low Back Pain, Mechanical and Piriformis Syndrome, run by Loma Linda University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Roya Vahdatinia, DO (9095586202, rvahdatinia@llu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Algometer - Change in pressure pain threshold (time frame: Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in